Overview
Jeffrey Barnes, MD, PhD, is a medical oncologist at the Massachusetts General Hospital Cancer Center's Comprehensive Cutaneous Lymphoma Program and Center for Lymphoma.
- Departments
-
- Centers & Specialties
- Clinical Interests
-
- Chronic lymphocytic leukemia (CLL)
- Cutaneous b-cell lymphoma
- Cutaneous t-cell lymphoma
- Hodgkin's lymphoma (also known as Hodgkin's disease)
- Non-Hodgkin's lymphoma (NHL)
- Medical Education
-
- MD, PhD, University of Illinois College of Medicine at Urbana-Champaign
- Residency, Beth Israel Deaconess Medical Center
- Fellowship, Dana Farber Cancer Institute
- Board Certifications
-
- Internal Medicine
- Hematology
- Medical Oncology
- Locations
-
- Boston: Massachusetts General Hospital
- Martha's Vineyard: Martha?s Vineyard Hospital
- Nantucket: Cottage Hospital
- Insurances Accepted
-
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- MassHealth
- Medicare
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Adult
- Gender
- Male
Biography
Research & Publications
- Research Summary
- Dr.Barnes performs translational research in lymphoma including clinical trials of novel therapies for the treatment of cutaneous lymphoma, non-Hodgkin lymphomas, Hodgkin lymphoma (Hodgkin's disease), and chronic lymphocytic leukemia.
- Publications
Barnes JA, Abramson JS. Differential Diagnosis and Novel Treatment Strategies for Adult T Cell Leukemia Lymphoma. Oncology. Dec 23;14, p.1267-1270 (2009)
Abramson JS, Hellmann M, Barnes JA, Hammermann P, Toomey C, Takvorian T, Muzikansky A, Hochberg EP. Intravenous methotrexate as central nervous system prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer Jun 8 Epub ahead of print (2010)
Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuburg D, Tomey C, Hochberg EP, Canellos GP, Abramson JS. End of treatment but not interim PET scan predicts outcomes in non-bulky limited stage Hodgkin lymphoma. Ann of Oncology Oct 15 (2010)
Barnes JA, LaCasce AS, Feng Y, Tomey C, Neuburg D, Michaelson JS, Hochberg EP, Abramson JS. Evaluation of the Addition of Rituximab to CODOX-M/IVAC for Burkitt Lymphoma: A Retrospective Analysis. Ann of Oncology In Feb 21 (2011)
Contact
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Fax: 617-726-8330
57 Prospect Street
Nantucket, MA 02554
Phone: 508-825-8100